World Health Energy Holdings (WHEN) Ratios
World Health Energy Holdings Ratios
WHEN's free cash flow for Q3 2025 was $-920.40M. For the 2025 fiscal year, WHEN's free cash flow was decreased by $-5.83M and operating cash flow was $-283.96K. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.00 | 0.35 | 0.35 | 1.72 | 0.78 |
| Quick Ratio | 0.00 | 0.34 | 0.28 | 0.16 | 0.78 |
| Cash Ratio | 0.00 | 0.06 | 0.07 | 0.06 | 0.69 |
| Solvency Ratio | -0.85 | -1.80 | 1.01 | -1.48 | -0.32 |
| Operating Cash Flow Ratio | -0.00 | -1.50 | -1.20 | -1.05 | -1.24 |
| Short-Term Operating Cash Flow Coverage | -3.64 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -5.15M | $ -3.62M | $ -3.67M | $ -1.80M | $ -2.03M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.19 | 0.21 | 0.21 | 1.40 | 3.96 |
| Debt-to-Equity Ratio | 0.44 | 0.82 | 0.88 | -1.47 | -0.91 |
| Debt-to-Capital Ratio | 0.31 | 0.45 | 0.47 | 3.13 | -10.67 |
| Long-Term Debt-to-Capital Ratio | 0.27 | 0.44 | 0.45 | 4.08 | -10.67 |
| Financial Leverage Ratio | 2.26 | 3.93 | 4.15 | -1.05 | -0.23 |
| Debt Service Coverage Ratio | -3.66 | 0.00 | 0.00 | -62.76 | 0.00 |
| Interest Coverage Ratio | -5.67 | 0.00 | 0.00 | -63.58 | 0.00 |
| Debt to Market Cap | 0.06 | 0.02 | 0.02 | 0.03 | 0.08 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -0.75 | -0.30 | -0.21 | -0.49 | -1.66 |
| Profitability Margins | |||||
| Gross Profit Margin | 26.13% | 91.04% | 87.45% | -3128.51% | 80.69% |
| EBIT Margin | -2518.54% | -3322.03% | -10909.83% | -3228.51% | -931.87% |
| EBITDA Margin | -2468.90% | -3313.07% | -10897.29% | -3187.10% | -891.69% |
| Operating Profit Margin | -2463.46% | -3322.03% | -10909.83% | -3228.51% | -931.87% |
| Pretax Profit Margin | -2952.80% | -3394.36% | -10915.69% | -3279.29% | -889.16% |
| Net Profit Margin | -2827.23% | -3360.16% | 4364.57% | -3330.07% | -846.46% |
| Continuous Operations Profit Margin | -2952.80% | -3394.36% | -10915.69% | -3279.29% | -889.16% |
| Net Income Per EBT | 95.75% | 98.99% | -39.98% | 101.55% | 95.20% |
| EBT Per EBIT | 119.86% | 102.18% | 100.05% | 101.57% | 95.42% |
| Return on Assets (ROA) | -29.12% | -68.43% | 38.86% | -293.88% | -181.35% |
| Return on Equity (ROE) | -65.77% | -268.70% | 161.11% | 307.26% | 41.91% |
| Return on Capital Employed (ROCE) | 0.33% | -72.78% | -105.25% | -549.11% | 1407.08% |
| Return on Invested Capital (ROIC) | 0.33% | -72.35% | -104.61% | -520.23% | 1407.08% |
| Return on Tangible Assets | -329.47% | -1382.13% | 737.77% | -293.88% | -181.35% |
| Earnings Yield | -8.68% | -6.71% | 3.20% | -7.73% | -3.56% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.43 | 1.51 | 0.66 | 1.98 | 2.52 |
| Payables Turnover | 1.12 | 0.17 | 0.11 | 56.53 | 0.72 |
| Inventory Turnover | 6.97 | 3.96 | 0.21 | 3.81 | 0.00 |
| Fixed Asset Turnover | 1.21 | 1.21 | 0.43 | 0.61 | 3.77 |
| Asset Turnover | 0.01 | 0.02 | 0.01 | 0.09 | 0.21 |
| Working Capital Turnover Ratio | -0.00 | -0.42 | 4.95 | 0.65 | -0.35 |
| Cash Conversion Cycle | -18.00 | -1763.94 | -1118.94 | 273.87 | -361.50 |
| Days of Sales Outstanding | 255.91 | 241.04 | 554.67 | 184.49 | 144.68 |
| Days of Inventory Outstanding | 52.39 | 92.13 | 1773.63 | 95.84 | 0.00 |
| Days of Payables Outstanding | 326.31 | 2097.11 | 3447.24 | 6.46 | 506.18 |
| Operating Cycle | 308.30 | 333.17 | 2328.31 | 280.33 | 144.68 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | -208.03 | -34.75 | -35.18 | -89.48 | -26.81 |
| Capital Expenditure Coverage Ratio | -208.03 | -34.75 | -35.18 | -89.48 | -26.81 |
| Operating Cash Flow Coverage Ratio | -0.46 | -0.51 | -0.44 | -0.36 | -0.36 |
| Operating Cash Flow to Sales Ratio | -8.71 | -5.17 | -10.36 | -5.70 | -6.62 |
| Free Cash Flow Yield | -2.69% | -1.06% | -0.78% | -1.34% | -2.89% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 0.25 | -14.90 | 31.29 | -12.94 | -28.10 |
| Price-to-Sales (P/S) Ratio | 325.74 | 500.76 | 1365.60 | 431.00 | 237.83 |
| Price-to-Book (P/B) Ratio | 7.58 | 40.04 | 50.41 | -39.77 | -11.78 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -37.22 | -94.09 | -128.21 | -74.77 | -34.65 |
| Price-to-Operating Cash Flow Ratio | -37.40 | -96.80 | -131.86 | -75.60 | -35.94 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.45 | -0.66 | -0.04 | -0.25 |
| Enterprise Value Multiple | -13.94 | -15.42 | -12.74 | -14.01 | -28.33 |
| Enterprise Value | 57.15M | 106.08M | 126.54M | 62.60M | 24.80M |
| EV to EBITDA | -13.94 | -15.42 | -12.74 | -14.01 | -28.33 |
| EV to Sales | 344.23 | 510.73 | 1388.76 | 446.59 | 252.63 |
| EV to Free Cash Flow | -39.34 | -95.97 | -130.39 | -77.47 | -36.80 |
| EV to Operating Cash Flow | -39.52 | -98.73 | -134.09 | -78.34 | -38.18 |
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Shareholders’ Equity Per Share | 0.00 | 0.00 | 0.00 | -0.00 | -0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.00 | 0.00 | -0.00 | -0.00 |
| Tax Burden | 0.96 | 0.99 | -0.40 | 1.02 | 0.95 |
| Interest Burden | 1.17 | 1.02 | 1.00 | 1.02 | 0.95 |
| Research & Development to Revenue | 7.70 | 9.32 | 15.26 | 3.55 | 4.98 |
| SG&A to Revenue | 17.20 | 24.86 | 94.80 | 29.62 | 5.08 |
| Stock-Based Compensation to Revenue | 15.67 | 27.66 | 99.10 | 24.87 | 0.00 |
| Income Quality | 0.29 | 0.15 | 0.09 | 0.17 | 0.74 |
Currency in USD
